Edition:
United Kingdom

Diffusion Pharmaceuticals Inc (DFFN.OQ)

DFFN.OQ on NASDAQ Stock Exchange Capital Market

3.66USD
24 May 2019
Change (% chg)

$-1.11 (-23.27%)
Prev Close
$4.77
Open
$4.20
Day's High
$4.20
Day's Low
$3.50
Volume
159,027
Avg. Vol
75,181
52-wk High
$10.98
52-wk Low
$1.85

About

Diffusion Pharmaceuticals Inc., formerly RestorGenex Corporation, is a clinical-stage biotechnology company. The Company is focused on developing standard-of-care treatments, including radiation therapy and chemotherapy. The Company's lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC)... (more)

Overall

Beta: 0.00
Market Cap(Mil.): $12.37
Shares Outstanding(Mil.): 3.38
Dividend: --
Yield (%): --

Financials

  DFFN.OQ Industry Sector
P/E (TTM): -- 93.20 35.48
EPS (TTM): -5.38 -- --
ROI: -77.90 7.47 11.75
ROE: -85.31 7.94 16.52

Earnings vs. Estimates